ELV Earnings & Financial Statements
Elevance Health Inc.
$428.09
+$2.82(+0.66%)
71
Overall
100
Value
63
Tech
50
Quality
Market Cap
$92.84B
Volume
2.12M
52W Range
$274.84 - $436.24
Target Price
$449.67
ELV earnings and financial statements: Elevance Health Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ELV Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $199.13B | $177.01B | $171.34B | $156.59B | $138.64B |
| Operating income | -$24.18B | -$21.70B | -$18.95B | -$6.83B | -$5.05B |
| Net income | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B |
| EPS (diluted) | $25.21 | $25.68 | $25.22 | $24.81 | $24.73 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $121.49B | $116.89B | $108.93B | $102.75B | $97.46B |
| Total liabilities | $77.47B | $75.46B | $69.52B | $66.42B | $61.33B |
| Shareholders’ equity | $43.88B | $41.31B | $39.31B | $36.24B | $36.06B |
| Cash and equivalents | $9.49B | $8.29B | $6.53B | $7.39B | $4.88B |
| Long-term debt | - | $29.22B | - | - | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $4.29B | $5.81B | $8.06B | $8.40B | $8.36B |
| Capital expenditure | - | -$1.26B | -$1.30B | -$1.15B | -$1.09B |
| Free cash flow | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B |
| Dividends paid | $1.53B | $1.51B | $1.40B | $1.23B | $1.10B |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELV | $428.09 | +0.7% | 2.12M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |